Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 7

2 Introduction 8

• 2.1 Coronary Artery Bypass Graft Surgery Overview 8

3 Products under Development 9

• 3.1 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 9
• 3.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment 10
• 3.3 Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory 11
• 3.4 Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path 12
• 3.5 Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date 13
• 3.6 Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials 14

4 Coronary Artery Bypass Graft Surgery - Pipeline Products under Development by Companies 15

• 4.1 Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development 15
• 4.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 17

5 Coronary Artery Bypass Graft Surgery Companies and Product Overview 18

• 5.1 AdvanSource Biomaterials Corporation Company Overview 18
  • 5.1.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
• 5.2 Axcelon Biopolymers Corp. Company Overview 19
  • 5.2.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 19
• 5.3 CardioPolymers Inc Company Overview 20
  • 5.3.1 CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview 20
• 5.4 Cardious Inc Company Overview 21
  • 5.4.1 Cardious Inc Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.5 Centre Hospitalier Universitaire de Nice Company Overview 22
  • 5.5.1 Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview 22
• 5.6 Coromedic Ltd. Company Overview 23
  • 5.6.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
• 5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview 25
  • 5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 25
• 5.8 Elana bv Company Overview 26
  • 5.8.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 26
• 5.9 Graft-Loc Inc. Company Overview 27
  • 5.9.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
• 5.10 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 28
  • 5.10.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 28
• 5.11 Hancock Jaffe Laboratories Inc Company Overview 29
  • 5.11.1 Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 29
• 5.12 iiTech BV Company Overview 30
  • 5.12.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 30
• 5.13 McGill University Company Overview 32
  • 5.13.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 32
• 5.14 Medical 21 Inc Company Overview 33
  • 5.14.1 Medical 21 Inc Pipeline Products & Ongoing Clinical Trials Overview 33
• 5.15 Myocardial Assist Systems and Technology LLC Company Overview 34
  • 5.15.1 Myocardial Assist Systems and Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 34
• 5.16 Neograft Technologies Inc Company Overview 35
  • 5.16.1 Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 35
• 5.17 PetVivo Holdings Inc Company Overview 36
  • 5.17.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 36
• 5.18 RegenMedTX LLC Company Overview 37
  • 5.18.1 RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 37
• 5.19 Rox Medical Inc Company Overview 38
  • 5.19.1 Rox Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 38
• 5.20 SeamVad Ltd. Company Overview 41
  • 5.20.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
• 5.21 Surg Solutions SL Company Overview 42
  • 5.21.1 Surg Solutions SL Pipeline Products & Ongoing Clinical Trials Overview 42
• 5.22 Synovis Micro Companies Alliance Inc Company Overview 43
  • 5.22.1 Synovis Micro Companies Alliance Inc Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.23 Thoratec Corp Company Overview 44
  • 5.23.1 Thoratec Corp Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.24 Tissue Regeneration Technologies LLC Company Overview 45
  • 5.24.1 Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 45
• 5.25 University College London Company Overview 46
  • 5.25.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 46
• 5.26 University Hospital Basel Company Overview 47
  • 5.26.1 University Hospital Basel Pipeline Products & Ongoing Clinical Trials Overview 47
• 5.27 University of Arizona Company Overview 48
  • 5.27.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 48
• 5.28 University of California Los Angeles Company Overview 49
  • 5.28.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 49
• 5.29 University of Utah Company Overview 50
  • 5.29.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 50

6 Coronary Artery Bypass Graft Surgery- Recent Developments 51

• 6.1 Nov 19, 2019: Hancock Jaffe Medical Team to make presentations at 46th Annual VEITH Vascular Symposium 51
• 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 51
• 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 54
• 6.4 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors 55
• 6.5 Oct 31, 2019: Sanofi Q3 well on track 55

7 Appendix 146

• 7.1 Methodology 146
• 7.2 About GlobalData 149
• 7.3 Contact Us 149

Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2019" provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Artery Bypass Graft Surgery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Coronary Artery Bypass Graft Surgery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date